2024-03-28T22:50:40Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_8D8578A22825
2024-03-23T02:40:34Z
serval:BIB_8D8578A22825
Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
10.1016/j.ajo.2014.07.002
25034116
000342552900006
Mantel
I.
author
Schalenbourg
A.
author
Bergin
C.
author
Petrovic
A.
author
Weber
D.C.
author
Zografos
L.
author
article
2014
American Journal of Ophthalmology
1879-1891
0002-9394
journal
158
4
693-701.e2
Adult
Aged
Angiogenesis Inhibitors/therapeutic use
Antibodies, Monoclonal, Humanized/therapeutic use
Coloring Agents/diagnostic use
Female
Fluorescein Angiography
Glaucoma, Neovascular/prevention & control
Glaucoma, Neovascular/radiography
Humans
Indocyanine Green/diagnostic use
Intervention Studies
Intravitreal Injections
Iris/blood supply
Laser Coagulation
Male
Melanoma/radiotherapy
Middle Aged
Neovascularization, Pathologic/prevention & control
Neovascularization, Pathologic/radiography
Proton Therapy
Retrospective Studies
Uveal Neoplasms/radiotherapy
Vascular Endothelial Growth Factor A/antagonists & inhibitors
Young Adult
eng
60_published
peer-reviewed
Publication types: Comparative Study ; Journal Article
Publication Status: ppublish